reports
Alvotech signs U.S. agreement to expand access for newly approved high...
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab) Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar to Humira® The agreement broadens patient access and further commitment to availability of vital biologics in the U.S. and globally REYKJAVIK, Iceland, April 19, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the de...
Alvotech signs U.S. agreement to expand access for newly approved high...
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab) Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market the newly FDA approved high-concentration interchangeable biosimilar to Humira®The agreement broadens patient access and further commitment to availability of vital biologics in the U.S. and globally Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for p...
Alvotech gerir sölusamning í Bandaríkjunum um fyrstu líftæknilyfjahlið...
Alvotech gerir sölusamning í Bandaríkjunum um fyrstu líftæknilyfjahliðstæðuna í háum styrk með útskiptanleika við Humira Langtímasamningur hefur náðst við leiðandi innkaupaaðila lyfja í Bandaríkjunum um sölu- og dreifingu á líftæknilyfjahliðstæðu Alvotech í háum styrk með útskiptanleika við HumiraMeð þessum samningi eykst útbreiðsla hliðstæðunnar í Bandaríkjunum og aðgengi sjúklinga að hagkvæmari líftæknilyfjum Alvotech (NASDAQ: ALVO) tilkynnti í dag að félagið hefði gert langtímasamning við leiðandi innkaupaaðila lyfja í Bandaríkjunum um sölu og markaðssetningu á adalimumab-ryvk, fyrst...
Integrated Research Limited: 1 director
A director at Integrated Research Limited bought 260,000 shares at 0.378AUD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
WiseTech Global Limited: 2 directors
Two Directors at WiseTech Global Limited sold 226,030 shares at 89.280AUD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Moody's Ratings withdraws Yuexiu Property's issuer rating, assigns Ba1...
穆迪投资者服务公司 1*请注意新闻稿之英文原版已于香港时间4月18日发放穆迪评级撤销越秀地产的发行人评级，授予Ba1的公司家族评级并下调高级无抵押债务评级至Ba1；展望仍为负面 香港，2024年4月18日—中文新闻稿为英文的翻译件。如有出入，以英文稿为准。穆迪评级 (穆迪) 今天对越秀地产股份有限公司及其全资子公司采取以下评级行动：1. 撤销越秀地产Baa3的发行人评级并授予Ba1的公司家族评级；2. 将越秀地产中期票据计划的高级无抵押债务评级从(P)Baa3下调至(P)Ba1；3. 将卓裕控股有限公司中期票据计划 (由越秀地产提供担保) 的有支持高级无抵押债务评级从(P)Baa3下调至(P)...
Moody's Ratings withdraws Yuexiu Property's issuer rating, assigns Ba1...
Moody's Ratings (Moody's) has today taken the following rating actions on Yuexiu Property Company Limited and its wholly-owned subsidiaries: 1. Withdrawn Yuexiu Property's Baa3 issuer rating and assigned the company a Ba1 corporate family rating (CFR); 2. Downgraded to (P)Ba1 from (P)Baa3 the seni...
- Felix Fischer
Lucror Analytics - Morning Views Latam
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar. To request full and unrestricted access to Lucror’s research and analytics platform, please visit
- ABGSC Healthcare Research
- Sten Gustafsson
- Marine Leleux
- Maureen Schuller
- Suvi Platerink Kosonen
Bank Brunch/NBFI's liquidity preparedness, no S&P rating changes expec...
Financial Stability Board on Non-Bank Financial Institutions' liquidity preparedness to margin and collateral calls. No rating upgrades expected at S&P for Icelandic covered bonds following the rating agency's systemic importance reassessment. UniCredit confirms to call the US$1.25bn AT1 in June, the bank can easily absorb the negative impact on its substantial MDA buffer
Man Group PLC : Form 8.3 - Barratt Developments plc
Man Group PLC : Form 8.3 - Barratt Developments plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant secur...
- Marine Leleux
- Maureen Schuller
- Suvi Platerink Kosonen
Bank Brunch/NBFI's liquidity preparedness, no S&P rating changes expec...
Financial Stability Board on Non-Bank Financial Institutions' liquidity preparedness to margin and collateral calls. No rating upgrades expected at S&P for Icelandic covered bonds following the rating agency's systemic importance reassessment. UniCredit confirms to call the US$1.25bn AT1 in June, the bank can easily absorb the negative impact on its substantial MDA buffer
Fonix Mobile: 3 directors
Three Directors at Fonix Mobile sold 6,666,667 shares at 225p. The significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
Man Group PLC : Form 8.3 - International Paper Company
Man Group PLC : Form 8.3 - International Paper Company FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant se...
Man Group PLC : Form 8.3 - Mondi plc
Man Group PLC : Form 8.3 - Mondi plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form...
Form 8.3 - UK Commercial Property REIT
Form 8.3 - UK Commercial Property REIT 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this f...
Solutiance AG: 1 director
A director at Solutiance AG sold 100,000 shares at 2.000EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
- Bob Liao
Audio Note: Devolver Digital - Rebuild year
In this audio note, Zeus’ Bob Liao summarises the investment case for Devolver Digital. Devolver Digital encouragingly delivered 2023 results slightly ahead of expectations and provided a steady medium-term outlook that leads us to reiterate our 2024 Adjusted EBITDA estimates. Listen to the audio note below, and read the full research here.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.